• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌酐清除率:在无液体潴留和肌肉消耗的早期肝炎后肝硬化(Child A级)患者中,作为肾滤过指标并不充分。

Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting.

作者信息

DeSanto N G, Anastasio P, Loguercio C, Spitali L, Del Vecchio Blanco C, Corvinelli M, Cirillo M

机构信息

Department of Pediatrics, Seconda Università degli Studi, Naples, Italy.

出版信息

Nephron. 1995;70(4):421-4. doi: 10.1159/000188639.

DOI:10.1159/000188639
PMID:7477646
Abstract

Glomerular filtration rate (GFR) was measured in 19 patients with Child A liver cirrhosis by comparing the endogenous creatinine clearance with inulin clearance. Inulin clearance averaged 90 +/- 4.4 ml/min x 1.73 m2, while creatinine clearance averaged 122 +/- 7 ml/min x 1.73 m2 (p < 0.001). The overestimation of GFR by creatinine was present in 18 of 19 patients and was inversely correlated with inulin clearance (r = -0.452, p < 0.04). The data point to the unsuitability of creatinine as a marker of filtration in early posthepatitic cirrhosis (Child A).

摘要

通过比较内源性肌酐清除率和菊粉清除率,对19例Child A级肝硬化患者的肾小球滤过率(GFR)进行了测量。菊粉清除率平均为90±4.4 ml/min×1.73 m²,而肌酐清除率平均为122±7 ml/min×1.73 m²(p<0.001)。19例患者中有18例存在肌酐对GFR的高估,且与菊粉清除率呈负相关(r = -0.452,p<0.04)。这些数据表明肌酐不适用于作为肝炎后早期肝硬化(Child A级)滤过的标志物。

相似文献

1
Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting.肌酐清除率:在无液体潴留和肌肉消耗的早期肝炎后肝硬化(Child A级)患者中,作为肾滤过指标并不充分。
Nephron. 1995;70(4):421-4. doi: 10.1159/000188639.
2
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis.评估测量和计算的肌酐清除率作为肝硬化不同阶段肾小球滤过标志物的情况。
Clin Nephrol. 1999 Jun;51(6):341-7.
3
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.血清肌酐水平和肌酐清除率作为肝硬化中滤过标志物的局限性。
Arch Intern Med. 1994 Jan 24;154(2):201-5.
4
Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.西咪替丁给药与代偿期肝硬化患者的肾小管肌酐分泌
Clin Sci (Lond). 2002 Jan;102(1):91-8.
5
Glomerular filtration rate measurement in cirrhotic patients with renal failure.肝硬化合并肾衰竭患者的肾小球滤过率测量
Clin Nephrol. 1998 Dec;50(6):342-6.
6
Validity of endogenous creatinine clearance in low birthweight infants.低出生体重儿内生肌酐清除率的有效性
Pediatr Res. 1979 Sep;13(9):1012-4. doi: 10.1203/00006450-197909000-00013.
7
Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis.通过定时尿液收集测量的肌酐清除率在肝硬化患者中显著高估了肾小球滤过率:一项系统评价和个体患者荟萃分析。
Nephrol Dial Transplant. 2005 Aug;20(8):1617-22. doi: 10.1093/ndt/gfh839. Epub 2005 Apr 26.
8
Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients.基于胱抑素C计算肝硬化患者的肾小球滤过率
Nephrol Dial Transplant. 2006 Mar;21(3):660-4. doi: 10.1093/ndt/gfi305. Epub 2005 Dec 2.
9
Measurement of glomerular filtration rate by free vitamin B12 clearance.
Intern Med. 1993 Mar;32(3):194-6. doi: 10.2169/internalmedicine.32.194.
10
Creatinine clearance in renal disease. A reappraisal.肾脏疾病中的肌酐清除率。重新评估。
Br Med J. 1969 Oct 4;4(5674):11-4. doi: 10.1136/bmj.4.5674.11.

引用本文的文献

1
INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.国际肝脏研究协会(INASL)与国际肾脏病学会(ISN)关于肝肾同时患病患者管理的联合立场声明
J Clin Exp Hepatol. 2021 May-Jun;11(3):354-386. doi: 10.1016/j.jceh.2020.09.005. Epub 2020 Oct 9.
2
GFR Estimating Equations and Liver Disease.肾小球滤过率估算方程与肝脏疾病
Adv Chronic Kidney Dis. 2015 Sep;22(5):337-42. doi: 10.1053/j.ackd.2015.05.003.
3
Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.
血清胱抑素C水平是评估肝硬化腹水且血清肌酐水平正常患者肾功能的有用标志物。
Korean J Hepatol. 2011 Jun;17(2):130-8. doi: 10.3350/kjhep.2011.17.2.130.
4
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.一种半机械论模型,用于预测肝硬化对药物清除率的影响。
Clin Pharmacokinet. 2010 Mar;49(3):189-206. doi: 10.2165/11318160-000000000-00000.
5
Dose adjustment in patients with liver disease.肝病患者的剂量调整。
Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005.
6
Principles of drug administration in renal insufficiency.肾功能不全时的给药原则
Clin Pharmacokinet. 1997 Jan;32(1):30-57. doi: 10.2165/00003088-199732010-00002.